INVASIVE CANDIDIASIS
Clinical trials for INVASIVE CANDIDIASIS explained in plain language.
Never miss a new study
Get alerted when new INVASIVE CANDIDIASIS trials appear
Sign up with your email to follow new studies for INVASIVE CANDIDIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Pill-Form fungus fighter takes on deadly candida
Disease control Recruiting nowThis Phase 3 trial tests a new drug called fosmanogepix against standard treatments for life-threatening Candida bloodstream or organ infections. About 450 adults will be randomly assigned to receive either fosmanogepix (first by IV, then as a pill) or the usual IV caspofungin fo…
Matched conditions: INVASIVE CANDIDIASIS
Phase: PHASE3 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could 7 days of antifungals be enough for kids with blood infections?
Disease control Recruiting nowThis study compares a 7-day course of antifungal therapy to the standard 14-day course for children with uncomplicated candidemia (a blood infection caused by Candida fungus). About 420 children who have already received 7 days of treatment will be randomly assigned to stop or co…
Matched conditions: INVASIVE CANDIDIASIS
Phase: NA • Sponsor: Arkansas Children's Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC